|
|||||
|
|
Healthcare costs of fast-acting insulin analogues versus short-acting human insulin for Danish patients with type 2 diabetes on a basal-bolus regimen |
|
| Authors: | Christensen Torsten E Gundgaard Jens Pilgaard Trine |
| Institution: | Novo Nordisk A/S, Vandtaarnsvej 114, Soeborg, Denmark. tluc@novonordisk.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |